InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Friday, 03/24/2017 11:38:22 AM

Friday, March 24, 2017 11:38:22 AM

Post# of 462054
Our Doc was recently quoted as saying his main responsibility is to "ensure trials are designed to succeed".... It is fairly easy to extrapolate from that and conclude he does not have much (or any) time to baby sit what the stock does (especially day to day)... It is interesting now that somebody came out today and complained about the long delays for getting p3 going... pretty funny .... We are still running p2 and data still coming in, and likely well into PLANNING (i.e. Doc is focused so it will not fail) P3... The complaint about delay is targeted towards what the author knows is a huge weak spot with retail investors (Patience) and nothing else , since fundamentally the complaint is "meaningless"...
The other complaints about finances and fringe science do not even merit a rebuttal IMO (as they are so weak) and again only targeting what the author perceives as weaknesses within the psychology of retail investors... If any retail succumb then it likely is good overall as they should not be into bio investing IMO....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News